Seaport Research's Jay Goldberg is the only sell-side analyst tracked by FactSet to carry a sell rating on Nvidia's stock. While he applauded the company's latest results and forecast, he's not ...

Science done at U.S. institutions ought to line up with "what the administration is trying to accomplish," Linda McMahon said ...

Goodman has a track record of raising its earnings guidance during its fiscal year, so the absence of an upgrade alongside Wednesday's update on its third-quarter performance may disappoint investors.

Read about the class deviation issued by GSA for the Federal Acquisition Regulation Part 10 concerning market research.

Pharmacogenomics studies how individuals respond to drugs based on their genetic code. Using that knowledge to guide ...